D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 81 Citations 23,193 287 World Ranking 9226 National Ranking 5087

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Enzyme

Cystic fibrosis, Pediatrics, Newborn screening, Internal medicine and Immunoreactive trypsinogen are his primary areas of study. Philip M. Farrell studies Cystic fibrosis, focusing on Cystic fibrosis transmembrane conductance regulator in particular. The concepts of his Pediatrics study are interwoven with issues in Disease, Incidence and Public health.

His studies examine the connections between Newborn screening and genetics, as well as such issues in Prenatal diagnosis, with regards to Sphingomyelin, Lung volumes, Pulmonary surfactant and Amniotic fluid. Philip M. Farrell combines subjects such as Gastroenterology, Endocrinology and Gestation with his study of Internal medicine. The study incorporates disciplines such as Test, Dried blood and Sweat test in addition to Immunoreactive trypsinogen.

His most cited work include:

  • Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening. (799 citations)
  • Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. (786 citations)
  • Early Diagnosis of Cystic Fibrosis Through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth (706 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Cystic fibrosis, Internal medicine, Newborn screening, Pediatrics and Endocrinology. Philip M. Farrell combines subjects such as Pathology, Surgery and Intensive care medicine with his study of Cystic fibrosis. His research integrates issues of Gastroenterology and Amniotic fluid in his study of Internal medicine.

His Newborn screening research incorporates elements of Randomized controlled trial, Family medicine, Sweat test, Public health and Genetic counseling. His Pediatrics research is multidisciplinary, incorporating perspectives in Respiratory disease, Incidence, Respiratory distress, Disease and Malnutrition. His study looks at the relationship between Endocrinology and topics such as Fetus, which overlap with Dexamethasone.

He most often published in these fields:

  • Cystic fibrosis (54.81%)
  • Internal medicine (40.26%)
  • Newborn screening (30.65%)

What were the highlights of his more recent work (between 2009-2021)?

  • Cystic fibrosis (54.81%)
  • Newborn screening (30.65%)
  • Pediatrics (24.94%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cystic fibrosis, Newborn screening, Pediatrics, Internal medicine and Immunoreactive trypsinogen. His Cystic fibrosis research focuses on Cystic fibrosis transmembrane conductance regulator in particular. His Newborn screening research includes themes of Randomized controlled trial, Public health, Pathology, Family medicine and Sweat test.

His study in Pediatrics is interdisciplinary in nature, drawing from both Health related quality of life, Incidence, Percentile, Primary care and Menarche. The various areas that Philip M. Farrell examines in his Internal medicine study include Gastroenterology, Endocrinology and Cardiology. In his study, Sweat chloride and International Statistical Classification of Diseases and Related Health Problems is strongly linked to Medical diagnosis, which falls under the umbrella field of Immunoreactive trypsinogen.

Between 2009 and 2021, his most popular works were:

  • Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation (285 citations)
  • Recommendations for the classification of diseases as CFTR-related disorders (245 citations)
  • The future of cystic fibrosis care: a global perspective (152 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Enzyme

Philip M. Farrell spends much of his time researching Cystic fibrosis, Newborn screening, Pediatrics, Cystic fibrosis transmembrane conductance regulator and Immunoreactive trypsinogen. His Cystic fibrosis study incorporates themes from Surgery, Genetic testing, Intensive care medicine, Pulmonary function testing and Cohort. His Newborn screening study combines topics from a wide range of disciplines, such as Quality management, Meconium Ileus, Public health and Sweat test.

His work deals with themes such as Genetic counseling, Quality of life, International Statistical Classification of Diseases and Related Health Problems and Exocrine pancreatic insufficiency, which intersect with Pediatrics. His Cystic fibrosis transmembrane conductance regulator research integrates issues from Mutation, Disease, Pathology and Bioinformatics. His studies deal with areas such as Immunology and Medical diagnosis as well as Immunoreactive trypsinogen.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening.

Joseph L. Bobadilla;Milan Macek;Jason P. Fine;Philip M. Farrell.
Human Mutation (2002)

1247 Citations

Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

Philip M. Farrell;Beryl J. Rosenstein;Terry B. White;Frank J. Accurso.
The Journal of Pediatrics (2008)

1136 Citations

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

C. Castellani;H. Cuppens;M. Macek;J. J. Cassiman.
Journal of Cystic Fibrosis (2008)

712 Citations

Early Diagnosis of Cystic Fibrosis Through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth

Philip M. Farrell;Michael R. Kosorok;Michael J. Rock;Anita Laxova.
Pediatrics (2001)

706 Citations

Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus

Hideo Uno;Lon Lohmiller;Carol Thieme;Joseph W. Kemnitz.
Developmental Brain Research (1990)

607 Citations

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

Zhanhai Li;Michael R. Kosorok;Philip M. Farrell;Anita Laxova.
JAMA (2005)

570 Citations

Hyaline membrane disease.

P M Farrell;M E Avery.
The American review of respiratory disease (1975)

566 Citations

Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee.

B W Ramsey;P M Farrell;P Pencharz.
The American Journal of Clinical Nutrition (1992)

561 Citations

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

Philip M. Farrell;Terry B. White;Clement L. Ren;Sarah E. Hempstead.
The Journal of Pediatrics (2017)

482 Citations

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

Michael R. Kosorok;Lan Zeng;Susan E.H. West;Michael J. Rock.
Pediatric Pulmonology (2001)

457 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Philip M. Farrell

Felix Ratjen

Felix Ratjen

University of Toronto

Publications: 71

Bonnie W. Ramsey

Bonnie W. Ramsey

University of Washington

Publications: 58

Michael W. Konstan

Michael W. Konstan

Case Western Reserve University

Publications: 51

Stephen M. Stick

Stephen M. Stick

University of Western Australia

Publications: 50

Claude Férec

Claude Férec

Inserm : Institut national de la santé et de la recherche médicale

Publications: 45

Garry R. Cutting

Garry R. Cutting

Johns Hopkins University School of Medicine

Publications: 45

John P. Clancy

John P. Clancy

Cystic Fibrosis Foundation

Publications: 41

Andrew Bush

Andrew Bush

National Institutes of Health

Publications: 38

Mikko Hallman

Mikko Hallman

Oulu University Hospital

Publications: 37

Marcus A. Mall

Marcus A. Mall

Humboldt-Universität zu Berlin

Publications: 36

Scott C. Bell

Scott C. Bell

University of Queensland

Publications: 35

Claire E. Wainwright

Claire E. Wainwright

University of Queensland

Publications: 34

Peter R. Durie

Peter R. Durie

University of Toronto

Publications: 33

Wayne J. Morgan

Wayne J. Morgan

University of Arizona

Publications: 32

J. Stuart Elborn

J. Stuart Elborn

Queen's University Belfast

Publications: 32

Peter D. Sly

Peter D. Sly

University of Queensland

Publications: 30

Trending Scientists

Jianfei Cai

Jianfei Cai

Monash University

John W. Morgan

John W. Morgan

Stony Brook University

Gui-Song Xia

Gui-Song Xia

Wuhan University

N. F. de Rooij

N. F. de Rooij

École Polytechnique Fédérale de Lausanne

Tao Li

Tao Li

Dongguan University of Technology

George Z. Kyzas

George Z. Kyzas

International Hellenic University

Shahriar Mobashery

Shahriar Mobashery

University of Notre Dame

T. V. RajanBabu

T. V. RajanBabu

The Ohio State University

Irene J. Beyerlein

Irene J. Beyerlein

University of California, Santa Barbara

James G. Berardinelli

James G. Berardinelli

Montana State University

James H. McKerrow

James H. McKerrow

University of Montana

Sonja W. Scholz

Sonja W. Scholz

Johns Hopkins University

Andrew G. Brooks

Andrew G. Brooks

University of Melbourne

Xian-Guo Liu

Xian-Guo Liu

Sun Yat-sen University

Christophe Hézode

Christophe Hézode

Université Paris Cité

Something went wrong. Please try again later.